ADiTx Therapeutics Cash and Cash Equivalents 2011-2026 | ADTX

Annual Cash and Cash Equivalents ADiTx Therapeutics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
833 K	97.1 K	2.77 M	7.87 M	10.5 M	4.09 K	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
10.5 M	4.09 K	3.68 M

Quarterly Cash and Cash Equivalents ADiTx Therapeutics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
324 K	476 K	833 K	329 K	91.2 K	88.7 K	97.1 K	1.65 M	96 K	303 K	2.77 M	9.24 M	804 K	2.12 M	7.87 M	5.47 M	8.61 M	14 M	10.5 M	10.5 M	10.5 M	10.5 M	4.09 K	4.09 K	4.09 K	-	116 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
14 M	4.09 K	3.74 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	2.33 M	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	30 M	-	-24.86 %	$ 820 K	USA
ADMA Biologics ADMA	87.6 M	$ 16.49	-0.3 %	$ 3.93 B	USA
AgeX Therapeutics AGE	345 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
AbCellera Biologics ABCL	129 M	$ 3.59	-1.1 %	$ 1.07 B	Canada
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Midatech Pharma plc MTP	1.67 M	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	13.4 M	-	-	$ 2.17 B	USA
AlloVir ALVR	118 M	-	4.14 %	$ 49.1 M	USA
Apellis Pharmaceuticals APLS	466 M	$ 20.5	3.22 %	$ 2.59 B	USA
Aptorum Group Limited APM	3.5 M	$ 0.81	-1.57 %	$ 4.42 M	China
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	145 M	$ 75.14	-1.82 %	$ 1.45 B	USA
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
Autolus Therapeutics plc AUTL	240 M	$ 1.57	-3.68 %	$ 401 M	Britain
Adverum Biotechnologies ADVM	60.7 M	-	-	$ 86.2 M	USA
Athersys ATHX	37.4 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	61.6 M	-	1052.0 %	$ 415 M	USA
AVEO Pharmaceuticals AVEO	70.5 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	323 M	$ 163.09	-0.61 %	$ 8.11 B	USA
Champions Oncology CSBR	9.78 M	$ 6.0	-	$ 82 M	USA
BridgeBio Pharma BBIO	570 M	$ 65.5	-1.57 %	$ 12.5 B	USA
Brainstorm Cell Therapeutics BCLI	187 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	22.1 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	21.8 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	86.5 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	811 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	16.4 M	-	5.93 %	$ 314 M	Canada
Bellerophon Therapeutics BLPH	6.92 M	-	-74.18 %	$ 955 K	USA
BioLineRx Ltd. BLRX	10.4 M	$ 2.84	1.07 %	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	1.31 B	$ 60.3	-0.22 %	$ 11.6 B	USA
Burford Capital Limited BUR	322 M	$ 8.34	-0.48 %	$ 1.36 B	Britain
Cabaletta Bio CABA	193 M	$ 3.37	-1.75 %	$ 3.94 M	USA
AIkido Pharma AIKI	4.08 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	76.1 M	$ 3.04	-5.0 %	$ 1.09 M	USA
Galmed Pharmaceuticals Ltd. GLMD	6.95 M	$ 0.59	-	$ 549 K	Israel
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Capricor Therapeutics CAPR	14.7 M	$ 25.56	0.22 %	$ 684 M	USA